Skip to main content

Kinetics of Drug Action

  • Chapter
Pharmacokinetics

Abstract

We all probably agree that the rapid progress in pharmacokinetics observed over the past decade has not been matched by a rapid development in our knowledge of the kinetics of drug action. The main reasons for this can probably be found in our limited ability to obtain precise pharmacodynamic data, especially in humans, and in the emphasis pharmacologists place upon the determination of qualitative and quantitative measures of effect rather than the kinetic aspects of the effects. However, with a combined knowledge of the pharmacodynamic events at the receptor sites and the pharmacokinetic properties of a specific drug we can learn quite a lot about drug action.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T.W. Rail and L.S. Schleifer, Oxytocin, prostaglandins, ergot alkaloids and other agents, in: “The Pharmacological Basis of Therapeutics,” ( 6th Edition ), A.G. Gilman, L.S. Goodman and A. Gilman, eds., Macmillan, New York (1980), p. 946.

    Google Scholar 

  2. P.O. Edlund, The determination of ergot alkaloids in plasma by high performance liquid chromatography and fluorescence detection, J. Chromatogr. 226: 107–115 (1981).

    Article  PubMed  CAS  Google Scholar 

  3. K. Ekbom, L.K. Paalzow and E. Waldenlind, Low biological availability of ergotamine tartrate after oral dosing in cluster headache, Cephalalgia 1: 203–207 (1981).

    Article  PubMed  CAS  Google Scholar 

  4. J.J. Ibraheem, L.K. Paalzow and P. Tfelt-Hansen, Kinetics of ergotamine after intravenous and intramuscular administration in migrainous patients, Eur. J. Clin. Pharmacol. 23: 235–240 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. P. Tfelt-Hansen, J.H. Eickhoff and J. Olesen, The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: Methodological aspects and time effect curve, Acta Pharmacol. Toxicol. 47: 151–156 (1980).

    Article  CAS  Google Scholar 

  6. L.B. Sheiner, D.R. Stanski, S. Vozeh, R.D. Miller and J. Ham, Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-turbocurarine, Clin. Pharmacol. Ther. 25: 358–371 (1979).

    PubMed  CAS  Google Scholar 

  7. W.A. Colburn, Simultaneous pharmacokinetic and pharmacodynamic modeling, J. Pharmacokin. Biopharm. 9: 367–388 (1981).

    Article  CAS  Google Scholar 

  8. N.H.G. Holford and L.B. Sheiner, Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models, Clin. Pharmacokin. 6: 429–453 (1981).

    Article  CAS  Google Scholar 

  9. E. Mikkelsen, O. Ledeballe Pedersen, J.R. Ostergaard and S. Ellebaek Pedersen, Effects of ergotamine on isolated human vessels, Arch. Int. Pharmacodyn. 252: 241–252 (1981).

    CAS  Google Scholar 

  10. P.O. Edlund, Determination of apomorphine in plasma. A comparison between capillary gas chromatography with electron capture detection and HPLC with fluorescence detection, in preparation.

    Google Scholar 

  11. L.K. Paalzow and P.O. Edlund, Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: Studies on clonidine in the rat and cat, J. Pharmacokin. Biopharm. 7: 495–510 (1979).

    Article  CAS  Google Scholar 

  12. S. Christersson, M. Frisk-Holmberg and L.K. Paalzow, Steady- state plasma concentration of clonidine and its relation to the effects on blood pressure in normotensive rats, J. Pharm. Pharmacol. 31: 418–419 (1979).

    Article  PubMed  CAS  Google Scholar 

  13. L.K. Paalzow and P.O. Edlund, Pharmacokinetics of clonidine in the rat and cat, J. Pharmacokin. Biopharm. 7: 481–494 (1979).

    Article  CAS  Google Scholar 

  14. M. Frisk-Holmberg and L.K. Paalzow, to be published.

    Google Scholar 

  15. G.H.M. Paalzow and L.K. Paalzow, Yohimbine both increases and decreases nociceptive thresholds in rats: Evaluation of the dose-response relationship, Naunyn-Schmiedeberg’s Arch. Pharmacol. 322: 193–197 (1983).

    Article  CAS  Google Scholar 

  16. M.N. Caroll and R.K.S. Lim, Observations on the neuropharmacology of morphine and morphine-like analgesia, Arch. Int. Pharmacodyn. 125: 383–403 (1960).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Paalzow, L.K., Paalzow, G.H.M., Tfelt-Hansen, P. (1984). Kinetics of Drug Action. In: Benet, L.Z., Levy, G., Ferraiolo, B.L. (eds) Pharmacokinetics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2799-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2799-8_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9725-3

  • Online ISBN: 978-1-4613-2799-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics